statement of research e. m. de robertis from the … › derobertis › doc › statement of...
TRANSCRIPT
STATEMENT OF RESEARCH 1
Organ fields
Statement of Research E. M. De Robertis
From the renewal of an HHMI Investigatorship (October 2009)
Molecular Mechanisms of Embryonic Self-regulation
During the period under review, we discovered a biochemical pathway of
interacting extracellular proteins that explains, for the first time, the molecular
mechanism of self-regulation of a morphogenetic field. Three new principles
emerged. First, we found that long-range cell-cell communication during dorsal-
ventral (D-V) patterning occurs through the action of extracellular regulators of
growth factors that control the flow of BMPs, which are then released by Tolloid
proteinases at a distance from where they were produced1-4. Second, we discovered
that the D-V BMP and the anterior-posterior (A-P) Wnt signaling gradients are
integrated via phosphorylations of the transcription factor Smad1/5/8 by BMP
receptor (BMPR) and GSK3, a protein kinase regulated by Wnt5,6. Third, we
uncovered unexpected connections between cell division and protein degradation7
that open new cell biological directions of great promise for the next funding
period.
Within the organism, cells proliferate, differentiate and
die as part of groups of hundreds or thousands of cells, called
morphogenetic fields, that have the remarkable property of self-regenerating after
perturbations. Fields were first identified by Ross Harrison in amphibian embryos8. He
STATEMENT OF RESEARCH 2
found that half of the mesoderm of a future forelimb would induce a whole limb - not
half a limb - after transplantation8,9. The Xenopus blastula also forms a morphogenetic
field, which can be bisected and still give rise to well-patterned
identical twins10,11. Understanding self-regulation has been the
long-term goal of my research12.
Chordin as the key to Spemann’s Organizer
Embryonic cell differentiation is regulated by a D-V activity gradient of
BMPs (Bone Morphogenetic Proteins, part of the TGF-β superfamily of growth
factors), transduced through phosphorylation of the transcription factors Smad1/5/8.
This morphogen gradient determines embryonic tissues13-15.
For example, in the ectoderm, BMP inhibition induces
Central Nervous System (CNS) while high BMP signals
induce epidermis. The precise allocation of tissue types requires a reproducible and
resilient molecular mechanism.
In 1924, Hans Spemann and Hilde Mangold performed a transplantation
experiment that started a new era in embryology. They discovered that a small
group of dorsal cells, called the organizer, was able to respecify the host’s
embryonic field, inducing a Siamese twin including a complete CNS16. Spemann
received the 1935 Nobel Prize in Physiology for this discovery of embryonic
STATEMENT OF RESEARCH 3
induction by organizer. Using a Xenopus Spemann
organizer cDNA library, we isolated many secreted
molecules expressed in this tissue, such as Chordin, Frzb,
Crescent, and Cerberus11. Surprisingly, most of these proteins were novel and
functioned as inhibitors of growth factors, rather than as growth factors as we had
expected.
The key molecule for understanding embryonic induction by organizer tissue is
Chordin17, a BMP antagonist secreted in prodigious amounts by the organizer
(estimated at 33 nM in the gastrula extracellular space if uniformly distributed, but
reaching much higher levels on the dorsal side2). As shown in the previous period,
transplanted organizers depleted of Chordin (using antisense morpholino oligos18)
lose all embryonic inductive power19. Chordin and a co-factor called Twisted
gastrulation (Tsg) form a ternary complex with BMPs, via the Cysteine-rich (CR)
modules in Chordin20,21. This inhibits binding to BMPR and the complex can
diffuse in the intercellular space. Inhibition is
reversible, for Zinc metalloproteinases of the
Tolloid (Tld) family can cleave Chordin at two
specific sites, releasing BMPs for signaling22.
Parallel work by other researchers in
Drosophila23, zebrafish13, and various
STATEMENT OF RESEARCH 4
organisms24 has established that the Chd/Tsg/BMP/Tld biochemical pathway
constitutes the ancestral embryonic D-V patterning mechanism.
Self-regulation is mediated by dorsal and ventral signaling centers
During the period being considered, we showed that embryonic self-
regulation requires a ventral signaling center. A duel between the dorsal organizer
and the ventral center - which secrete distinct sets of antagonists and BMPs under
opposite transcriptional control – explains self-regulation. A molecular see-saw, in
which BMP signals activate ventral
genes and repress dorsal ones, generates
a self-adjusting gradient of BMP
activity1,2. We elucidated the
extracellular biochemical pathway
illustrated nearby, in which blue arrows
indicate transcriptional regulation by
Smad1/5/8, black arrows show the direct
protein-protein interactions demonstrated
biochemically in our laboratory, and red
arrows denote the flux of Chordin/Bmp
complexes towards more ventral regions, as discussed below.
STATEMENT OF RESEARCH 5
Self-regulation through opposite transcriptional control of BMPs
The ventral center expresses BMP4 and BMP7 and the dorsal center BMP2
and ADMP25-27. Expression of BMPs in dorsal tissue is paradoxical, because this is
the region of the embryo where BMP signaling is lowest. Bruno Reversade and I
found that when all four BMPs are depleted simultaneously, the embryonic field
collapses and the entire embryo becomes covered in CNS1. By grafting wild-type
tissues into BMP-depleted embryos, we demonstrated that both the dorsal and
ventral centers serve as sources of
BMPs that diffuse over long distances
in the embryo, rescuing CNS (marked
by Sox2) and epidermal (cytokeratin)
patterning. These two sources of BMP
signals originating from opposite poles of the embryo generate a self-regulating
gradient1.
Extracellular D-V communication via Sizzled, Crossveinless-2 and Tolloid
During this period we also found that the BMP gradient is established and
self-regulated through three novel extracellular protein-protein interactions.
Sizzled is a Xenopus sFRP (secreted Frizzled-related protein) expressed
ventrally28. With Hojoon Lee we discovered that Sizzled binds to tolloids via its
STATEMENT OF RESEARCH 6
frizzled domain2. In enzyme kinetic analyses, Sizzled was a competitive inhibitor of
Chordin cleavage, with a Ki in the same range (20 nM) as the Km of the Tolloid
enzyme for its substrate2. This reaction provides self-regulation, for when BMP
levels increase, Sizzled expression is upregulated, causing Chordin levels to
increase, inhibiting BMP and restoring the gradient.
Crossveinless-2 (CV2) is a ventral center secreted protein that contains five
Chordin-like CR modules, first cloned in Drosophila by Seth Blair29 and
subsequently by us in the mouse30. CV2 has pro-BMP effects in Drosophila wing
cross veins23,29. However, overexpressed CV2 is a strong BMP inhibitor that binds
BMPs preventing BMPR binding31-33. CV2 remains tethered via glypicans/Dally to
the surface of the cells that secrete it31,32, mediating endocytosis of BMPs34. With
Andrea Ambrosio we found the molecular explanation for the pro-BMP effects of
CV2: it binds with high affinity (1-2 nM) to Chordin protein3. CV2 binds with even
higher affinity to Chordin/BMP complexes or Chordin
fragments cleaved by Tolloid protease. Thus, CV2
functions as a molecular sink, concentrating
Chordin/BMP complexes diffusing from more dorsal
regions3. Once in the ventral side, BMPs are released
from Chordin by Tolloid, allowing maximal BMP signaling.
STATEMENT OF RESEARCH 7
Tolloid chordinase activity is critical to D-V patterning, so we developed a
new fluorogenic substrate, mimicking a Chordin cleavage sequence, for enzyme
kinetic studies4. We discovered that BMP4 is a non-competitive
inhibitor of Tolloid or BMP1 (an alternatively spliced form of this
enzyme). BMPs were initially purified as bone-inducing proteins
from bone matrix. BMP2-7 were TGF-β-related, but why the BMP1
proteinase co-purified as well had remained a mystery35. We found
that BMP4 binds specifically to the “CUB” domains of BMP1/Tolloid with high
affinity (KD 15-20 nM), establishing an enzymatic
negative feedback loop in the ventral side4.
These three novel protein-protein interactions – Sizzled-Tolloid, CV2-
Chordin, and Tolloid-BMP4 – help explain how the dorsal and ventral centers
communicate over long distances to maintain a self-adjusting signaling gradient.
MAPK activation inhibits Smad1, explaining “heterologous” neural inducers
We became interested in Smad1 after finding that neural induction by IGF
and FGF is caused by MAPK phosphorylations in the central “linker” region of
Smad136 that inhibit its nuclear activity37,38. During the 1930s, amphibian
experimental embryology ground to a halt when it was found that dead organizer
tissue, or non-specific substances such as nucleoproteins, sterols, and even sand
STATEMENT OF RESEARCH 8
particles, could cause CNS differentiation when placed in contact with salamander
ectodermal explants10,11. We found that the neural induction caused by dissociation
of Xenopus ectodermal cells is due to sustained activation of MAPK and Smad1/5/8
inhibition39. Using Ambystoma maculatum embryos over three breeding seasons
(Jan.-Feb.), Cecilia Hurtado and I showed that “heterologous” neural inductions,
such as culturing ectoderm attached to a glass surface or sandwiched around sand
particles, were caused by MAPK/Erk activation40. The heterologous inducers that
had brought down Spemann’s edifice have finally found a molecular explanation:
the activation of MAPK linker phosphorylations that inhibit Smad1/5/8.
Integrating A-P and D-V positional information via Smad1 phosphorylations
When twins are generated, the D-V and A-P body axes are seamlessly
integrated. Christof Niehrs (Heidelberg) has proposed that the A-P axis is
established by a gradient of Wnt, maximal in the posterior41. During our
investigations on neural induction, we noticed GSK3 sites in Smad1/5/8 that could
be primed by the MAPK linker sites5 (GSK3 phosphorylates substrates containing
Serine or Threonine four amino acids upstream of a pre-phosphorylated residue42).
This was very exciting, because the canonical Wnt pathway signals by regulating
the activity of GSK343.
STATEMENT OF RESEARCH 9
With Luis Fuentealba and Edward Eivers, we generated high-titer phospho-
specific antibodies for human pSmad1GSK3 and pSmad1MAPK, and Drosophila
pMadGSK3 and pMadMAPK. This allowed us to identify a novel cell biological
pathway that terminates Smad1 signaling5,6. After
activation of BMPR, Smad1 is sequentially
phosphorylated at C-terminal, MAPK, and GSK3 sites.
Phosphorylation by GSK3 is required for
polyubiquitinylation by Smurf1 E3 ligase, transport along
microtubules to the centrosomes, and proteasomal
degradation5. Epistatic experiments in Xenopus5 and
Drosophila6 showed that Wnt/Wg signaling inhibits Smad1/Mad phosphorylation
by GSK3, and that Smad1/Mad are required for many aspects of Wnt signaling.
Thus, we have discovered a new branch of the “canonical” Wnt pathway
(previously believed to signal exclusively by increasing β-Catenin levels), in which
Wnt increases the duration of the BMP/Smad1 signal.
Embryonic positional information may be encoded by a system of Cartesian
coordinates in which the D-V BMP and the A-P Wnt
gradients are integrated at the level of Smad1/5/8
phosphorylations5. In this view, the BMP gradient
determines the intensity (or amplitude) and the Wnt
STATEMENT OF RESEARCH 10
gradient the duration of Smad1/5/8 signals24. Smad1/5/8 are transcription factors
that coordinate the expression of hundreds of downstream target genes; this hard-
wired system of signaling integration may provide resilience to the embryonic body
plan.
Conclusions
During the period under review we discovered a biochemical pathway for the
self-regulation of the Xenopus embryonic field. Self-regulation is mediated by
extracellular signaling between dorsal and ventral signaling centers that secrete
cocktails of BMPs and their regulators. These centers self-adjust to signaling
changes in one another because they are under opposite transcriptional control by
BMPs. The D-V BMP gradient is integrated with the A-P Wnt gradient
intracellularly through phosphorylations of Smad1/5/8 by GSK3, such that Wnt
increases the duration of the BMP signals.
STATEMENT OF RESEARCH 11
References
1) Reversade, B. and De Robertis, E.M. (2005). Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field. Cell 123, 1147-1160.
2) Lee, H.X., Ambrosio, A.L., Reversade, B. and De Robertis, E.M. (2006). Embryonic dorsal-
ventral signaling: secreted Frizzled-related proteins as inhibitors of Tolloid proteinases. Cell 124, 147-159.
3) Ambrosio, A.L., Taelman, V.F., Lee, H.X., Metzinger, C.A., Coffinier, C. and De Robertis,
E.M. (2008). Crossveinless-2 is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. Dev. Cell 15, 248-260.
4) Lee, H.X., Mendes, F.A., Plouhinec, J.L. and De Robertis, E.M. (2009). Enzymatic
regulation of pattern: BMP4 binds CUB domains of Tolloids and inhibits proteinase activity. Manuscript submitted.
5) Fuentealba, L.C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E.M. and De
Robertis, E.M. (2007). Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993.
6) Eivers, E., Fuentealba, L.C., Sander, V., Clemens, J., Hartnett, L. and De Robertis, E.M.
(2009). Mad is required for wingless signaling in wing development and segment patterning in Drosophila. PLoS ONE, in press.
7) Fuentealba, L.C., Eivers, E., Geissert, D., Taelman, V. and De Robertis, E.M. (2008).
Asymmetric mitosis: Unequal segregation of proteins destined for degradation. Proc. Natl. Acad. Sci. USA 105, 7732-7737.
8) Harrison, R.G. (1918). Experiments on the development of the fore-limb of Amblystoma, a
self-differentiating equipotential system. J. Exp. Zool. 25, 413-461. 9) Huxley J.S. and de Beer, G.R. (1934). The Elements of Experimental Embryology,
Cambridge University Press, Cambridge. 10) Spemann, H. (1938). Embryonic Development and Induction. Yale University Press, New
Haven, Conn., reprinted by Hafner publishing company, 1962. 11) De Robertis, E.M. (2006). Spemann’s organizer and self-regulation in amphibian embryos.
Nature Rev. Mol. Cell Biol. 4, 296-302. 12) De Robertis, E.M., Morita, E.A. and Cho, K.W.Y. (1991). Gradient fields and homeobox
genes. Development 112, 669-678. 13) Little, S.C. and Mullins, M.C. (2006). Extracellular modulation of BMP activity in
patterning the dorsoventral axis. Birth Def. Res. 78, 224-242.
STATEMENT OF RESEARCH 12
14) Heasman, J. (2006). Patterning the early Xenopus embryo. Development 133, 1205-1217. 15) De Robertis, E.M. and Kuroda, H. (2004). Dorsal-ventral patterning and neural induction in
Xenopus embryos. Annu. Rev. Cell Dev. Biol. 20, 285-308. 16) Spemann, H. and Mangold, H. (1924). Induction of embryonic primordial by implantation
of organizers from a different species. Roux’s Arch. Entw. Mech. 100, 599-638. Reprinted and translated in Int. J. Dev. Biol. (2001) 45, 13-31.
17) Sasai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L.K. and De Robertis, E.M. (1994).
Xenopus Chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79, 779-790.
18) Heasman, J. (2002). Morpholino oligos: making sense or antisense? Dev. Biol. 15, 209-214. 19) Oelgeschläger, M., Kuroda, H., Reversade, B. and De Robertis, E. M. (2003). Chordin is
required for the Spemann organizer transplantation phenomenon in Xenopus embryos. Dev Cell 4, 219-230.
20) Piccolo, S., Sasai, Y., Lu, B. and De Robertis, E.M. (1996). Dorsoventral patterning in
Xenopus: Inhibition of ventral signals by direct binding of Chordin to BMP-4. Cell 86, 589-598.
21) Oelgeschläger, M., Larrain, J., Geissert, D. and De Robertis, E.M. (2000). The
evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling. Nature 405, 757-763.
22) Piccolo, S., Agius, E., Lu, B., Goodman, S., Dale, L. and De Robertis, E.M. (1997).
Cleavage of Chordin by the Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91, 407-416.
23) O’Connor, M.B., Umulis, D., Othmer, H.G, Blair, S.S. (2006). Shaping BMP morphogen
gradients in the Drosophila embryo and pupal wing. Development 133, 183-193. 24) De Robertis, E.M. (2008). Evo-Devo: Variations on Ancestral themes. Cell 132, 185-195. 25) Moos, M., Wang, S. and Krinks, M. (1995). Anti-dorsalizing morphogenetic protein is a
novel TGF-beta homolog expressed in the Spemann organizer. Development 121, 4293-4301.
26) Reversade, B., Kuroda, H., Lee, H., Mays, A. and De Robertis, E. M. (2005). Depletion of
Bmp2, Bmp4, Bmp7 and Spemann organizer signals induces massive brain formation in Xenopus embryos. Development 132, 3381-3392.
27) Inomata, H., Haraguchi, T. and Sasai, Y. (2008). Robust stability of the embryonic axial
pattern requires a secreted scaffold for Chordin degradation. Cell 134, 854-865.
STATEMENT OF RESEARCH 13
28) Collavin, L. and Kirschner, M. W. (2003). The secreted Frizzled-related protein Sizzled functions as a negative feedback regulator of extreme ventral mesoderm. Development 130, 805-816.
29) Conley, C.A., Silburn, R., Singer, M.A., Ralston, A., Rohwer-Nutter, D., Olson, D.J.,
Gelbart, W. and Blair, S.S. (2000). Crossveinless 2 contains cysteine-rich domains and is required for high levels of BMP-like activity during the formation of the cross veins in Drosophila. Development 127, 3947-3959.
30) Coffinier, C., Ketpura, N., Tran, U., Geissert, D. and De Robertis, E.M. (2002). Mouse
Crossveinless-2 is the vertebrate homolog of a Drosophila extracellular regulator of BMP signaling. Mech. Dev. 119, 179-184.
31) Rentzsch, F., Zhang, J., Kramer, C., Sebald, W. and Hammerschmidt, M. (2006).
Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation. Development 133, 801-811.
32) Serpe, M., Umulis, D., Ralston, A., Chen, J., Olson, D.J., Avanesov, A., Othmer, H.,
O'Connor, M.B. and Blair, S.S. (2008). The BMP-Binding Protein Crossveinless 2 Is a Short-Range, Concentration-Dependent, Biphasic Modulator of BMP Signaling in Drosophila. Dev. Cell 14, 940-953.
33) Zhang, J., Qiu, L., Kotzsch, A., Patterson, L., Hammerschmidt, M., Sebald, W. and Mueller,
T.D. (2008). Crystal structure analysis reveals how the chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev. Cell 14, 739-750.
34) Kelley, R., Ren, R., Pi, X., Wu, Y., Moreno, I., Willis, M., Moser, M., Ross, M., Podkowa,
M., Attisano, L. and Patterson, C. (2009). A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. J. Cell Biol. 184, 597-609.
35) Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick,
R.M. and Wang, E.A. (1988). Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534.
36) Pera, E.M., Ikeda, A., Eivers E. and De Robertis E.M. (2003). Integration of IGF, FGF, and
anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev. 17, 3023-3028.
37) Kretzschmar, M., Doody, J. and Massagué. (1997). Opposing BMP and EGF signaling
pathways converge on the TGF-β family mediator Smad1. Nature. 389, 618-622. 38) Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H. and Massagué, J. (2007).
Balancing BMP signaling through integrated outputs into the Smad linker. Mol. Cell, 25, 441-454.
STATEMENT OF RESEARCH 14
39) Kuroda, H., Fuentealba, L., Ikeda, A., Reversade, B. and De Robertis, E.M. (2005). Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev. 19, 1022-1027.
40) Hurtado, C. and De Robertis, E.M. (2007). Neural induction in the absence of organizer in
salamanders is mediated by MAPK. Dev. Biol. 307, 282-289. 41) Niehrs, C. (2004). Regionally specific induction by the Spemann-Mangold organizer. Nat.
Rev. Genet. 6, 425-434. 42) Cohen, P. and Frame, S. (2001). The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-
776. 43) Logan, C.Y. and Nusse, R. (2004). The Wnt signaling pathway in development and disease.
Annu. Rev. Cell Dev. Biol. 20, 781-810.